Akoya Biosciences, Inc. (AKYA)
USD 1.03
(-11.97%)
USD 1.03
(-11.97%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 180.36 Million USD | 2.46% |
| 2022 | 176.03 Million USD | -7.79% |
| 2021 | 190.9 Million USD | 145.82% |
| 2020 | 77.66 Million USD | -13.14% |
| 2019 | 89.41 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 154.75 Million USD | -14.2% |
| 2024 Q2 | 143.74 Million USD | -7.11% |
| 2023 Q1 | 154.29 Million USD | -12.35% |
| 2023 FY | 180.36 Million USD | 2.46% |
| 2023 Q3 | 177.24 Million USD | -6.16% |
| 2023 Q2 | 188.87 Million USD | 22.41% |
| 2023 Q4 | 180.36 Million USD | 1.76% |
| 2022 Q2 | 184.26 Million USD | -1.53% |
| 2022 Q1 | 187.12 Million USD | -1.98% |
| 2022 Q4 | 176.03 Million USD | -0.24% |
| 2022 FY | 176.03 Million USD | -7.79% |
| 2022 Q3 | 176.45 Million USD | -4.24% |
| 2021 Q4 | 190.9 Million USD | -2.3% |
| 2021 Q2 | 206.34 Million USD | 177.04% |
| 2021 Q1 | 74.48 Million USD | -4.09% |
| 2021 FY | 190.9 Million USD | 145.82% |
| 2021 Q3 | 195.41 Million USD | -5.3% |
| 2020 Q4 | 77.66 Million USD | 0.0% |
| 2020 FY | 77.66 Million USD | -13.14% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 89.41 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AngioDynamics, Inc. | 317.67 Million USD | 43.221% |
| AtriCure, Inc. | 613.93 Million USD | 70.621% |
| Avinger, Inc. | 13.77 Million USD | -1209.869% |
| Azenta, Inc. | 2.88 Billion USD | 93.75% |
| BioLife Solutions, Inc. | 412.71 Million USD | 56.297% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 98.453% |
| Daxor Corporation | 34.86 Million USD | -417.274% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -523.726% |
| Femasys Inc. | 27.75 Million USD | -549.842% |
| GlucoTrack, Inc. | 4.9 Million USD | -3577.248% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -31.305% |
| Hologic, Inc. | 9.15 Billion USD | 98.03% |
| ICU Medical, Inc. | 4.37 Billion USD | 95.881% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 98.832% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -533.742% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 47.987% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -2800.4% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -2800.4% |
| Masimo Corporation | 3.04 Billion USD | 94.07% |
| Microbot Medical Inc. | 8.32 Million USD | -2066.074% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -4.917% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 92.243% |
| Nephros, Inc. | 11.86 Million USD | -1420.69% |
| NovoCure Limited | 1.14 Billion USD | 84.263% |
| NEXGEL, Inc. | 9.95 Million USD | -1711.843% |
| NEXGEL, Inc. | 9.95 Million USD | -1711.843% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 32.056% |
| OraSure Technologies, Inc. | 482.84 Million USD | 62.645% |
| Pro-Dex, Inc. | 54.21 Million USD | -232.723% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -196.64% |
| Predictive Oncology Inc. | 14.41 Million USD | -1151.064% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -966.479% |
| QuidelOrtho Corporation | 8.56 Billion USD | 97.894% |
| Repligen Corporation | 2.82 Billion USD | 93.614% |
| Sanara MedTech Inc. | 73.87 Million USD | -144.167% |
| STAAR Surgical Company | 488.69 Million USD | 63.091% |
| Sharps Technology, Inc. | 11.78 Million USD | -1429.942% |
| Utah Medical Products, Inc. | 135.45 Million USD | -33.155% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 97.553% |
| Jin Medical International Ltd. | 32.9 Million USD | -448.177% |